Stephen Tomlinson, Ph.D., is a professor and interim chair of the Department of Pharmacology & Immunology in the College of Medicine at the Medical University of South Carolina (MUSC). He also has served in academic leadership roles focused on research strategy and faculty development. Dr. Tomlinson received his undergraduate training at the University of Leeds and earned his Doctor of Philosophy (Ph.D.) in from the University of Cambridge, followed by postdoctoral training at the University of Florida. He joined the MUSC faculty in 2000.
Dr. Tomlinson’s research centers on the complement system and its role in inflammation, tissue injury, and immune mediated disease. His work spans neuroinflammation, ischemic and traumatic brain injury, transplantation, autoimmunity, and cancer, with a strong emphasis on translational science. His laboratory is recognized for developing site targeted complement inhibitors designed to suppress harmful complement activation at sites of injury while preserving systemic immune function. His research has resulted in numerous peer reviewed publications, patents, and technologies advancing toward clinical application.
In addition to his research program, Dr. Tomlinson is actively involved in mentoring trainees and junior faculty and contributes to interdisciplinary collaborations across MUSC’s research enterprise.
Focus: The complement system in inflammation, alloimmunity, cancer immunity and CNS injury.
Tomlinson Lab
